Literature DB >> 11252736

Portal vein stenting to treat portal vein tumor thrombus in hepatocellular carcinoma.

I Higaki1, K Hirohashi, S Kubo, H Tanaka, T Tsukamoto, T Omura, H Kinoshita.   

Abstract

Tumor thrombus in the portal vein is refractory to therapy and a serious negative prognostic factor in hepatocellular carcinoma. We describe herein the case of a patient in whom an expandable metallic stent was successfully employed to treat portal vein tumor thrombus by restoring blood flow. An expandable metallic stent was implanted in a patient with severe main portal vein stenosis caused by tumor thrombus protruding from the left portal vein branch. Immediately after stent placement, the stenotic lesion was effectively dilated, the portal blood flow restored, and portal hypertension relieved. Angiography, computed tomography, and doppler ultrasonography done 2 months after the stent placement revealed continued patency of the portal vein. Thus, intraportal placement of an expandable metallic stent appears to be an effective treatment for major portal vein tumor

Entities:  

Mesh:

Year:  2000        PMID: 11252736

Source DB:  PubMed          Journal:  Osaka City Med J        ISSN: 0030-6096


  5 in total

1.  Portal vein stenting to treat portal vein stenosis in a patient with malignant tumor and gastrointestinal bleeding.

Authors:  Katsunobu Sakurai; Ryosuke Amano; Akira Yamamoto; Norifumi Nishida; Shinya Matsutani; Keiichiro Hirata; Kenjiro Kimura; Kazuya Muguruma; Takahiro Toyokawa; Naoshi Kubo; Hiroaki Tanaka; Masakazu Yashiro; Masaichi Ohira; Kosei Hirakawa
Journal:  Int Surg       Date:  2014 Jan-Feb

2.  Portal venous stent placement for treatment of portal hypertension caused by benign main portal vein stenosis.

Authors:  Hong Shan; Xiang-Sheng Xiao; Ming-Sheng Huang; Qiang Ouyang; Zai-Bo Jiang
Journal:  World J Gastroenterol       Date:  2005-06-07       Impact factor: 5.742

3.  Treatment of portal vein tumor thrombus of hepatocellular carcinoma with percutaneous laser ablation.

Authors:  Zheng-Hua Lu; Feng Shen; Zhen-Lin Yan; Jun Li; Jia-He Yang; Ming Zong; Le-Hua Shi; Meng-Chao Wu
Journal:  J Cancer Res Clin Oncol       Date:  2008-11-26       Impact factor: 4.553

4.  Transarterial chemoembolisation (TACE) combined with endovascular implantation of an iodine-125 seed strand for the treatment of hepatocellular carcinoma with portal vein tumour thrombosis versus TACE alone: a two-arm, randomised clinical trial.

Authors:  Minjie Yang; Zhuting Fang; Zhiping Yan; Jianjun Luo; Lingxiao Liu; Wen Zhang; Linlin Wu; Jingqin Ma; Qinghui Yang; Qingxin Liu
Journal:  J Cancer Res Clin Oncol       Date:  2013-12-28       Impact factor: 4.553

5.  Portal Vein Stenting Combined with 125I Particle Chain Implantation Followed by As2O3 in the Treatment of Hepatocellular Carcinoma with Portal Vein Tumour Thrombus.

Authors:  Zhaonan Li; Guangyan Si; De-Chao Jiao; Xinwei Han; Wenguang Zhang; Yahua Li; Xueliang Zhou; Juanfang Liu; Jianjian Chen
Journal:  Biomed Res Int       Date:  2020-01-31       Impact factor: 3.411

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.